share_log

Vibe Reports Third Quarter 2023

Vibe Reports Third Quarter 2023

Vibe 2023 年第三季度報告
newsfile ·  2023/11/30 19:00

Sacramento, California--(Newsfile Corp. - November 30, 2023) - Vibe Growth Corporation (CSE: VIBE) (OTCQB: VIBEF) (the "Company" or "Vibe"), a vertically integrated California cannabis enterprise, has released its 2023 third quarter financial results. All financial information is provided in U.S. dollars unless otherwise indicated. The Condensed Consolidated Financial Statements and Management Discussion and Analysis ("MD&A") for the three and nine months ended September 30, 2023, are available on the Company's SEDAR+ profile at and Vibe's website at .

加利福尼亞州薩克拉門託--(新聞文件公司-2023 年 11 月 30 日)-Vibe Growth Corporation (案例:VIBE)(OTCQB: VIBEF) (那個”公司“或”氛圍“) 是一家垂直整合的加州大麻企業,已發佈其2023年第三季度財務業績。除非另有說明,否則所有財務信息均以美元提供。截至2023年9月30日的三個月和九個月的簡明合併財務報表和管理層討論與分析(“MD&A”)可在公司的SEDAR+簡介和Vibe的網站上查閱。

Third Quarter 2023 Highlights

2023 年第三季度亮點

  • As of September 30, 2023, Vibe's cash position was $2.8 million;
  • Dispensary Gross Margin increased to 49.7% in the quarter and 41.9% in the 2023 nine-month period compared to 33.6% and 36.6% in the comparative three and nine-month periods of 2022(1);
  • EBITDA and Adjusted EBITDA of $1,170,807 and $281,672 in the 2023 third quarter compared to EBITDA loss and adjusted EBITDA loss of $641,893 and $557,056 in the second quarter of 2023;
  • In the nine-month period, the Company generated EBITDA of $153,643 and an Adjusted EBITDA loss of $772,270; and
  • Revenues were $3.39 million for the third quarter of 2023, compared to $3.69 in the second quarter of 2023, representing an 8.1% decrease.
  • 截至2023年9月30日,Vibe的現金狀況爲280萬美元;
  • 藥房毛利率在本季度增至49.7%,在2023年九個月期間增至41.9%,而2022年的三個月和九個月同期分別爲33.6%和36.6%(1);
  • 2023年第三季度的息稅折舊攤銷前利潤和調整後息稅折舊攤銷前利潤爲1,170,807美元和281,672美元,而2023年第二季度的息稅折舊攤銷前利潤虧損爲641,893美元和557,056美元;
  • 在九個月期間,公司的息稅折舊攤銷前利潤爲153,643美元,調整後的息稅折舊攤銷前利潤虧損爲772,270美元;以及
  • 2023年第三季度的收入爲339萬美元,而2023年第二季度的收入爲3.69美元,下降了8.1%。

(1) This is a non-IFRS measure. Readers are cautioned that the amounts presented do not have standardized meanings prescribed by IFRS. Please see the non-GAAP Financial Measures Disclosure below.

(1) 這是一項非國際財務報告準則的衡量標準。提醒讀者,所列金額不具有《國際財務報告準則》規定的標準含義。請參閱下面的非公認會計准則財務指標披露。

Financial Highlights

財務要聞

The Company's key financial results for the three and nine months ended September 30, 2022, and 2021 are as follows:

公司截至2022年9月30日和2021年9月30日的三個月和九個月的主要財務業績如下:

U.S. Dollars For the three months
ended September 30, 2023
For the three months
ended
September 30, 2022
For the nine
months
ended September 30, 2023
For the nine
months
ended
September 30, 2022
Total revenue(a) $3,396,007 $5,522,473 $11,090,258 $16,921,735
Gross margin $2,059,572 $1,853,723 $4,789,215 $6,200,133
Net loss $(1,1340,946) $(1,130,063) $(3,887,059) $(2,775,042)
EBITDA(a) $1,170,807 $(450,381) $153,643 $(371,235)
Adjusted EBITDA(a) $281,672 $(208,643) $(772,270) $115,668
美元 在這三個月裏
已於 2023 年 9 月 30 日結束
在這三個月裏
已結束
2022年9月30日
對於九個人
月份
已於 2023 年 9 月 30 日結束
對於九個人
月份
已結束
2022年9月30日
總收入(a) 3,396,007 美元 5,522,473 美元 11,090,258 美元 16,921,735 美元
毛利率 2,059,572 美元 1,853,723 美元 4,789,215 美元 6,200,133 美元
淨虧損 $ (1,1340,946) $ (1,130,063) $ (3,887,059) $ (2,775,042)
EBITDA(a) 1,170,807 美元 $ (450,381) 153,643 美元 $ (371,235)
調整後 EBITDA(a) 281,672 美元 $ (208,643) $ (772,270) 115,668 美元

Special Note Regarding non-GAAP Financial Measures

關於非公認會計准則財務指標的特別說明

  1. This is a non-GAAP measure. Readers are cautioned that the amounts presented do not have standardized meanings prescribed by IFRS. See discussion of non-IFRS Measures in the MD&A for reconciliation to measures reported in the Company's consolidated financial statements.
  1. 這是一項非公認會計准則的衡量標準。提醒讀者,所列金額不具有《國際財務報告準則》規定的標準含義。參見MD&A中對非國際財務報告準則指標的討論,以了解與公司合併財務報表中報告的指標的對賬。

Vibe chief executive officer, Mark Waldron, commented: "In the third quarter, we started to see the results of the groundwork for centralized purchasing and internal distribution, leading to improvements to Vibe's dispensary gross margins. We've launched several new Hype products and continue to focus our marketing efforts on supporting the new product launches and Vibe continues to implement cost reductions by reducing head office staffing levels."

Vibe首席執行官馬克·沃爾德隆評論說:“在第三季度,我們開始看到集中採購和內部分銷基礎工作的結果,從而提高了Vibe的藥房毛利率。我們已經推出了幾款新的Hype產品,並將繼續將營銷工作重點放在支持新產品的發佈上,Vibe繼續通過減少總部人員配備水平來降低成本。”

About Vibe Growth Corporation

關於 Vibe 增長公司

Vibe Growth Corporation and its cannabis retail brand, Vibe By California, is a trusted, vertically integrated California cannabis enterprise with retail dispensaries; cannabis greenhouse cultivation; premium indoor cultivation; commercial cannabis distribution; brand sales and marketing; e-commerce platform; home delivery; and Hype Cannabis Co. marijuana and Vibe CBD products. In California, Vibe is focused on maximizing shareholder value through accelerating organic growth, opportunistic acquisitions, distressed workouts, and new license applications. The Company operates retail and e-commerce under its iconic Vibe By California brand.

Vibe Growth Corporation及其大麻零售品牌Vibe By California是一家值得信賴的垂直整合加州大麻企業,擁有零售藥房、大麻溫室種植、優質室內種植、商用大麻分銷、品牌銷售和營銷、電子商務平台、送貨上門以及Hype Cbannabis Co.的大麻和Vibe CBD產品。在加利福尼亞州,Vibe專注於通過加速有機增長、機會主義收購、不良鍛鍊和新的許可證申請來最大限度地提高股東價值。該公司以其標誌性的Vibe By California品牌經營零售和電子商務。

To learn more about Vibe, please visit:

要了解有關 Vibe 的更多信息,請訪問:

Company Contact

公司聯繫人

Investor Relations
Email: ir@vibebycalifornia.com
Website:

投資者關係
電子郵件:ir@vibebycalifornia.com
網站:

Cautionary Note Regarding Product & Forward-Looking Information

關於產品和前瞻性信息的警示說明

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performances. The use of any of the words "anticipate," "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions or statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events, and maybe impacted as a result of general economic conditions. In this news release, forward-looking statements relate to, among other things, the Company's expectations of revenue, EBITDA profitability and adjusted funds flow, higher sales volumes, and the Company's retail operations. Actual future results may differ materially.

本新聞稿中包含的某些陳述構成前瞻性信息。這些陳述與未來的活動或未來的演出有關。使用 “預期”、“可能”、“打算”、“期望”、“相信”、“將”、“預測”、“估計” 等詞語以及與非歷史事實的事項有關的類似表達或陳述,均旨在識別前瞻性信息,並基於各方當前對此類未來事件的結果和時機的信念或假設,並可能受到總體經濟狀況的影響。在本新聞稿中,前瞻性陳述涉及公司對收入的預期、息稅折舊攤銷前利潤率和調整後的資金流、更高的銷售量以及公司的零售業務等。未來的實際結果可能存在重大差異。

The forward-looking information contained in this release is made as of the date hereof, and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein. Risk factors related to the Company are described in the Company's Management Discussion and Analysis, a copy of which is available under the Company's profile on SEDAR.

本新聞稿中包含的前瞻性信息自本文發佈之日起生成,除非適用的證券法要求,否則各方沒有義務更新或修改任何前瞻性信息,無論是由於新信息、未來事件還是其他原因造成的。由於此處包含的風險、不確定性和假設,投資者不應過分依賴前瞻性信息。上述陳述明確限定了此處包含的任何前瞻性信息。公司的管理層討論與分析中描述了與公司相關的風險因素,該討論與分析的副本可在SEDAR上的公司簡介下找到。

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any State securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. securities laws.

本新聞稿不構成出售要約或招攬購買美國任何證券的要約。這些證券過去和將來都不會根據經修訂的1933年《美國證券法》(“美國證券法”)或任何州證券法進行註冊,除非根據美國證券法和適用的州證券法註冊或者可以豁免此類註冊,否則不得在美國境內或向美國個人發行或出售。不適用於向美國新聞通訊社發行或在美國傳播。任何不遵守此限制的行爲都可能構成對美國證券法的違反。

Unlike in Canada, which has Federal legislation uniformly governing the cultivation, distribution, sale, and possession of medical cannabis under the Cannabis Act (Federal), readers are cautioned that in the U.S., cannabis is largely regulated at the State level. To the knowledge of Vibe Growth Corporation, there are, to date, a total of 33 states, plus the District of Columbia, that have legalized cannabis in some form. Notwithstanding the permissive regulatory environment of medical cannabis at the State level, cannabis continues to be categorized as a controlled substance under the Controlled Substances Act in the U.S., and as such, cannabis-related practices or activities, including, without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. Strict compliance with state laws concerning cannabis will neither absolve Vibe of liability under the U.S. Federal law nor will it provide a defense to any Federal proceeding which may be brought against Vibe Growth Corporation. Any such proceedings brought against Vibe may adversely affect its operations and financial performance.

與加拿大不同,加拿大根據《大麻法》(聯邦),聯邦立法統一管理醫用大麻的種植、分配、銷售和持有,但讀者請注意,在美國,大麻主要受州一級的監管。據Vibe Growth Corporation所知,迄今爲止,共有33個州加上哥倫比亞特區,已將某種形式的大麻合法化。儘管在州一級對醫用大麻有寬鬆的監管環境,但根據美國《管制物質法》,大麻仍被歸類爲受管制物質,因此,根據美國聯邦法律,與大麻相關的做法或活動,包括但不限於大麻的製造、進口、擁有、使用或分銷是非法的。嚴格遵守有關大麻的州法律既不能免除Vibe在美國聯邦法律下的責任,也不會爲可能對Vibe Growth Corporation提起的任何聯邦訴訟提供辯護。對Vibe提起的任何此類訴訟都可能對其運營和財務業績產生不利影響。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論